The Next Frontier in Wet AMD - Summary - MDSpire
Feature

The Next Frontier in Wet AMD

AI-driven therapy planning is turning OCT from a monitoring tool into a forecasting engine for retina specialists

  • By

  • Adam Dubis

  • May 11, 2026

  • 4 min

Share

Artificial intelligence is revolutionizing the treatment of wet age-related macular degeneration (AMD) by enhancing the way clinicians interpret data from optical coherence tomography (OCT). AI enables tailored injection schedules based on individual disease trajectories, moving beyond traditional treatment regimens. It identifies patterns in patient adherence and treatment outcomes, aiming to sustain optimal vision preservation. Tools like deepeye® TPS utilize AI to forecast disease activity and help patients and clinicians better plan and align treatment regimens with patients’ lives, representing a significant shift towards personalized patient care.

Original Source(s)

The Next Frontier in Wet AMD

  • by Adam Dubis

  • May 11, 2026

Related Content

The Smart Contact Lens Evolves

New research shows how microstructured contact lenses can track eye movements with remarkable accuracy using Moiré patterns

  • May 12, 2026

  • 3 min
CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min
Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.